We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Boston Scientific (BSX) Com Stk US $0.01

Sell:$67.42 Buy:$67.43 Change: $0.63 (0.93%)
Market closed |  Prices as at close on 15 April 2024 | Switch to live prices |
Change: $0.63 (0.93%)
Market closed |  Prices as at close on 15 April 2024 | Switch to live prices |
Change: $0.63 (0.93%)
Market closed |  Prices as at close on 15 April 2024 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Boston Scientific Corporation is a global developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. The Company’s segments include MedSurg and Cardiovascular. The MedSurg segment includes Endoscopy, Urology and Neuromodulation. Its Endoscopy business develops and manufactures devices to diagnose and treat a broad range of gastrointestinal (GI) and pulmonary conditions with less invasive technologies. Its Urology business develops and manufactures devices to treat various urological conditions for both male and female anatomies. Its Neuromodulation business develops and manufactures devices to treat various neurological movement disorders and manage chronic pain. The Cardiovascular segment includes Cardiology and Peripheral Interventions. The Company's Interventional Cardiology Therapies business develops and manufactures technologies for diagnosing and treating coronary artery disease and aortic valve conditions.

Contact details

300 Boston Scientific Way
United States
+1 (508) 6834000

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
Market cap:
$100.06 billion
Shares in issue:
1.47 billion
Health Care Equipment
New York Stock Exchange
United States
US dollar

Key personnel

  • Michael Mahoney
    Chairman of the Board, President, Chief Executive Officer
  • Daniel Brennan
    Chief Financial Officer, Executive Vice President
  • Wendy Carruthers
    Executive Vice President - Human Resources
  • Arthur Butcher
    Executive Vice President, Group President, MedSurg and Asia Pacific
  • Joseph Fitzgerald
    Executive Vice President, Group President - Cardiology
  • Jeffrey Mirviss
    Executive Vice President and President - Peripheral Interventions
  • John Sorenson
    Executive Vice President - Global Operations
  • Eric Thepaut
    Executive Vice President and President - Europe, Middle East and Africa
  • Emily Woodworth
    Senior Vice President, Chief Accounting Officer, Controller
  • Vance Brown
    Senior Vice President, General Counsel, Corporate Secretary

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.


The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.